Shah, Furqan A. http://orcid.org/0000-0002-9876-0467
Sayardoust, Shariel http://orcid.org/0000-0003-3738-1217
Omar, Omar http://orcid.org/0000-0002-2610-1294
Thomsen, Peter http://orcid.org/0000-0003-3910-6665
Palmquist, Anders http://orcid.org/0000-0002-6974-2577
Funding for this research was provided by:
Vetenskapsrådet
Article History
Received: 24 June 2019
Accepted: 27 August 2019
First Online: 18 September 2019
Compliance with Ethical Standards
:
: Furqan A. Shah, Shariel Sayardoust, Omar Omar, Peter Thomsen, and Anders Palmquist declare that they have no conflict of interest.
: The study protocol was approved by the Institutional Review Board at the University of Linköping (Dnr 2016/319-31). Informed consent was obtained from all participants. The study was conducted in accordance with the guidelines of Good Clinical Practice for Trials on Medicinal Products in the European Community, the International Conference on Harmonisation (ICH) guideline for Good Clinical Practice, the Declaration of Helsinki, and the CONSORT guidelines for clinical studies.